Plan Group Financial’s Gilead Sciences GILD Stock Holding History

Plan Group Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$285K	Buy	+2,044	New	+$286K	0.07%	176

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Plan Group Financial's GILD Position: Q1 2026 in Review

Plan Group Financial opened a new position in Gilead Sciences (GILD) in Q1 2026: 2,044 shares worth $285K. The stake represents 0.07% of the portfolio and ranks #176 among its holdings.

2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Plan Group Financial held 2,044 shares of Gilead Sciences worth $285K as of Q1 2026.
Gilead Sciences was a new Plan Group Financial position in Q1 2026.
Gilead Sciences made up 0.07% of Plan Group Financial's portfolio in Q1 2026, its #176 holding.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Plan Group Financial's 13F filing for Q1 2026, filed 13 Apr 2026.